Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque. However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles. Here we show that a decline in the autophagy–lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques. By augmenting macrophage TFEB, the master transcriptional regulator of autophagy–lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis. In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy–lysosomal biogenesis and show trehalose’s ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression. Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Atherosclerosis | Macrophage‐specific overexpression of Tfeb | Reduced development of atherogenic plaque after stimulation of lysosomal biogenesis in macrophages | Sergin et al (2017) |”
From Autophagy in major human diseases (2021) · cites this paper as Sergin et al (2017)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., Hengartner, M. O., & Green, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113421108 · Cited by 655
RetractedA SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069 · cited 2×
“In addition, dual TFEB-TG/ ATG5-KO macrophages subjected to atherogenic lipids were no longer able to (1) reduce the number of p62-enriched protein aggregates or (2) blunt the degree of apoptosis (Fig.”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Self-citationNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Self-citationA Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Self-citationNew insights on trehalose: a multifunctional molecule
Elbein, A. D. (2003) · Glycobiology · doi:10.1093/glycob/cwg047 · Cited by 1,954
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“The NLRP3 inflammasome, therefore, appears to warrant further investigation as a potential target for inflamm-aging related to atherosclerosis given that such mechanisms are now of well known importance in atherosclerosis (353).”
BackgroundOuimet, M., Barrett, T. J., & Fisher, E. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.312617 · Cited by 761
Puertollano, R., Ferguson, S. M., Brugarolas, J., & Ballabio, A. (2018) · The EMBO Journal · doi:10.15252/embj.201798804 · Cited by 531
Self-citationSelective autophagy of intracellular organelles: Recent research advances
Li, W., He, P., Huang, Y., Li, Y.-F., Lu, J., Li, M., Kurihara, H., Luo, Z., Meng, T., Onishi, M., et al. (2021) · Theranostics · doi:10.7150/thno.49860 · Cited by 507
“It has been uncovered that LSDs are associated with autoimmune phenomena [349], cholesterol homeostasis [350], cardiovascular diseases [351, 352], and NDDs [353].”
BackgroundMacrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?
Parisi, L., Gini, E., Baci, D., Tremolati, M., Fanuli, M., Bassani, B., Farronato, G., Bruno, A., & Mortara, L. (2018) · Journal of Immunology Research · doi:10.1155/2018/8917804 · Cited by 508
“Stimulation of the macrophage autophagy-lysosomal system by the natural sugar trehalose has been reported to reduce the formation of the atherosclerotic plaque by limitingmacrophage apoptosis and necrosis in the plaque cores [225].”
BackgroundAutophagy in liver diseases: Time for translation?
Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.026 · Cited by 378
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 356
“Unfortunately, atherosclerotic plaque development did impair autophagy conversely in macrophages [61, 62] accounting for cholesterol crystal accumulation and dysfunctional mitochondria, which are responsible for inflammasome hyperactivation, M1-like polarization, and apoptosis [63].”
BackgroundLysosomal Biology and Function: Modern View of Cellular Debris Bin
Trivedi, P. C., Bartlett, J. J., & Pulinilkunnil, T. (2020) · Cells · doi:10.3390/cells9051131 · Cited by 296
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Guerriero, J. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.006 · Cited by 293
Deng, R.-H., Zou, M.-Z., Zheng, D., Peng, S.-Y., Liu, W., Bai, X.-F., Chen, H.-S., Sun, Y., Zhou, P.-H., & Zhang, X.-Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b02993 · Cited by 230
Self-citationTargeting lysosomes in human disease: from basic research to clinical applications
Cao, M., Luo, X., Wu, K., & He, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00778-y · Cited by 225
Lysosomal storage disorders – challenges, concepts and avenues for therapy: beyond rare diseases
Marques, A. R. A., & Saftig, P. (2019) · Journal of Cell Science · doi:10.1242/jcs.221739 · Cited by 224
“lysosomal biogenesis in macrophages by upregulation of TFEB as a therapeutic avenue for atherosclerosis (Evans et al., 2018; Sergin et al., 2017) (Fig.”
BackgroundInfluentialFang, S., Wan, X., Zou, X., Sun, S., Hao, X., Liang, C., Zhang, Z., Zhang, F., Sun, B., Li, H., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-020-03357-1 · Cited by 222
Macrophage Death as a Pharmacological Target in Atherosclerosis
Martinet, W., Coornaert, I., Puylaert, P., & De Meyer, G. R. Y. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00306 · Cited by 221
High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy
Zhang, X., Sergin, I., Evans, T. D., Jeong, S.-J., Rodriguez-Velez, A., Kapoor, D., Chen, S., Song, E., Holloway, K. B., Crowley, J. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0162-4 · Cited by 191
Self-citationLysosomal Acid Lipase in Lipid Metabolism and Beyond
Li, F., & Zhang, H. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312136 · Cited by 182
“apoptotic and proinflammatory effects of atherogenic lipid loading in mouse peritoneal macrophage(42) and reduced atherosclerosis in mice model.(43)”
BackgroundDeficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis
Qiao, L., Ma, J., Zhang, Z., Sui, W., Zhai, C., Xu, D., Wang, Z., Lu, H., Zhang, M., Zhang, C., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318908 · Cited by 179
p62/ SQSTM1 and Selective Autophagy in Cardiometabolic Diseases
Jeong, S.-J., Zhang, X., Rodriguez-Velez, A., Evans, T. D., & Razani, B. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7649 · Cited by 165
“Atherosclerotic plaques are no exception and both human and murine samples feature marked p62 accumulation (21, 95, 96).”
Self-citationAutophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y.-L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 164
“first described the functional status of the autophagylysosome system in murine and human atherosclerotic plaques through two key autophagy markers LC3 and SQSTM1/p62 (Sergin et al., 2017).”
BackgroundInfluentialYuan, Y., Chen, Y., Peng, T., Li, L., Zhu, W., Liu, F., Liu, S., An, X., Luo, R., Cheng, J., et al. (2019) · Clinical Science · doi:10.1042/cs20190672 · Cited by 158
Lysosomes in senescence and aging
Tan, J. X., & Finkel, T. (2023) · EMBO reports · doi:10.15252/embr.202357265 · Cited by 151
“…2022), such as LSDs (Palmieri et al , 2017; Lotfi et al , 2018), Parkinson’s disease (Khalifeh et al , 2019; Pupyshev et al , 2019), atherosclerosis (Sergin et al , 2017; Evans et al , 2018), amyotrophic lateral sclerosis (ALS) (Zhang et al , 2014), and frontotemporal dementia (Holler et al ,…”
Proteomic Architecture of Human Coronary and Aortic Atherosclerosis
Herrington, D. M., Mao, C., Parker, S. J., Fu, Z., Yu, G., Chen, L., Venkatraman, V., Fu, Y., Wang, Y., Howard, T. D., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034365 · Cited by 151
Microglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
Berglund, R., Guerreiro-Cacais, A. O., Adzemovic, M. Z., Zeitelhofer, M., Lund, H., Ewing, E., Ruhrmann, S., Nutma, E., Parsa, R., Thessen-Hedreul, M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5077 · Cited by 149
“The enriched LXR pathway in Atg7fl/fl Cx3cr1CreERT2 microglia resembled the macrophage phenotype characteristic of atherosclerosis, a disease state in which there is pathogenic accumulation of intracellular lipid compounds (63).”
BackgroundDefective autophagy in atherosclerosis: to die or to senesce?
Grootaert, M. O. J., Roth, L., Schrijvers, D. M., De Meyer, G. R. Y., & Martinet, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7687083 · Cited by 147
“The morphological evidence for autophagy has been further supported by Western blot and immunohistochemical analyses of advanced human plaques showing elevated levels of the autophagosomal marker LC3-II [13, 25].”
BackgroundJeong, S., Stitham, J., Evans, T. D., Zhang, X., Rodríguez-Vélez, A., Yeh, Y., Tao, J., Takabatake, K., Epelman, S., Lodhi, I. J., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1896906 · Cited by 157
“We first assessed the effect of trehalose on primary murine macrophages as we have previously shown its ability to robustly activate TFEB and the autophagy-lysosomal biogenesis response [20,22] Trehalose triggered nuclear translocation of TFEB at all concentrations tested (100 uM, 1 mM, and 10 mM) on par with bafilomy…”
BackgroundSelf-citationMitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases
Liu, Y., Huang, Y., Xu, C. B., An, P., Luo, Y., Jiao, L., Luo, J., & Li, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416053 · Cited by 159
“Atherosclerosis mtDNA mutation Impaired mitophagy ↓OXPHOS ↑ROS [24] clinical, 2019 [25] experimental, 2017 [26] experimental, 2018 [27] experimental, 2017 [28] experimental, 2019 [29] experimental, 2021 [30] experimental, 2014”
Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB–P300–BRD4 axis
Li, X., Zhu, R., Jiang, H., Yin, Q., Gu, J., Chen, J., Ji, X., Wu, X., Fu, H., Wang, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.014 · Cited by 151
Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production
Viaud, M., Ivanov, S., Vujić, N., Duta-Mare, M., Aira, L. E., Barouillet, T., Garcia, E., Orange, F., Dugail, I., Hainault, I., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312333 · Cited by 156
Endothelial shear stress signal transduction and atherogenesis: From mechanisms to therapeutics
He, L., Zhang, C., Chen, Q., Wang, L., & Huang, Y. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108152 · Cited by 150
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Lu, G. X., Wang, Y., Shi, Y. P., Zhang, Z., Huang, C., He, W., Wang, C., & Shen, H. (2022) · MedComm · doi:10.1002/mco2.150 · Cited by 147
Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Song, Y., Huang, Y., Zhou, F., Ding, J., & Zhou, W. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.090 · Cited by 120
Robichaud, S., Rasheed, A., Pietrangelo, A., Kim, A. D., Boucher, D. M., Emerton, C., Vijithakumar, V., Gharibeh, L., Fairman, G., Mak, E., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.320047 · Cited by 126
Yu, W., Liu, W., Xie, D., Wang, Q., Xu, C., Zhao, H., Lv, J., He, F., Chen, B., Yamamoto, T., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9304383 · Cited by 121
LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
Wallings, R. L., Connor‐Robson, N., & Wade‐Martins, R. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz088 · Cited by 121
“To assess whether the accumulation of autophagosomes in LRRK2-R1441C neurons could be rescued by increasing lysosome number, neuronal cultures were treated with 500 μm trehalose, a compound known to induce lysosomal biogenesis (28).”
MethodLysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies
Zhang, H. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000507 · Cited by 120
Zhang, H., Song, G., Ni, B., He, K., Zhu, P., Wu, X., & Shao, Y. (2021) · Autophagy · doi:10.1080/15548627.2021.1909833 · Cited by 109
Protective role of chaperone-mediated autophagy against atherosclerosis
Madrigal-Matute, J., de Bruijn, J., van Kuijk, K., Riascos-Bernal, D. F., Diaz, A., Tasset, I., Martín-Segura, A., Gijbels, M. J. J., Sander, B., Kaushik, S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121133119 · Cited by 107
“Interestingly, genetic up-regulation in vivo of either of them, by overexpressing the positive regulator of macroautophagy TFEB (67) or the limiting CMA component LAMP-2A (this work), successfully slows down atherosclerotic disease progression in mice.”
BackgroundAn FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
Wang, Y., Gunewardena, S., Li, F., Matye, D. J., Chen, C., Chao, X., Jung, T., Zhang, Y., Czerwiński, M., Ni, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17363-6 · Cited by 105
Wu, Z., Zhou, M., Tang, X., Zeng, J., Li, Y., Sun, Y., Huang, J., Chen, L., Wan, M., & Mao, C. (2022) · ACS Nano · doi:10.1021/acsnano.1c08391 · Cited by 99
A role for lipophagy in atherosclerosis
Laval, T., & Ouimet, M. I. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00885-z · Cited by 97
Ma, W., Sun, X.-J., Wang, Y., Zhu, Y., Han, X., & Liu, N. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.08.012 · Cited by 92
Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections
Robinson, J. I., Weir, W. H., Crowley, J. R., Hink, T., Reske, K. A., Kwon, J. H., Burnham, C. D., Dubberke, E. R., Mucha, P. J., & Henderson, J. P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126905 · Cited by 91
Self-citationZhao, Y., Jia, X., Yang, X., Bai, X., Lu, Y., Zhu, L., Cheng, W., Shu, M., Zhu, Y., Du, X., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155162 · Cited by 92
Immunometabolism and immune response regulate macrophage function in atherosclerosis
Xue, S., Su, Z., & Liu, D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101993 · Cited by 102
Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation
Zhong, S., Li, L., Zhang, Y., Zhang, L., Lu, J., Guo, S., Liang, N., Ge, J., Zhu, M., Tao, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122064 · Cited by 92
“Furthermore, a recent study explored autophagy-lysosomal biogenesis as a potential therapeutic strategy for atherosclerosis (5, 7).”
Classical and alternative roles for autophagy in lipid metabolism
Zhang, X., Evans, T. D., Jeong, S., & Razani, B. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000509 · Cited by 92
Self-citationLipid and Non-lipid Factors Affecting Macrophage Dysfunction and Inflammation in Atherosclerosis
Gibson, M. S., Domingues, N. S., & Vieira, O. V. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00654 · Cited by 90
“More recently, TFEB overexpression was shown to reverse the gradual decline in the autophagy–lysosome system that occurs in lipid loaded cells with dysfunctional lysosomes, abolishing apoptosis and reducing IL1β production, and consequently atherosclerosis (Sergin et al., 2017).”
BackgroundImmunometabolic function of cholesterol in cardiovascular disease and beyond
Yvan‐Charvet, L., Bonacina, F., Guinamard, R., & Norata, G. D. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz127 · Cited by 90
“biogenesis prevented the pro-inflammatory and pro-apoptotic effects of atherogenic lipid loading.(72) Inversely, LIPA deficiency in iPSC-derived macrophages promoted cholesterol accumulation(65) and perturbed lipophagy as a mean to promote NLRP3 inflammasome activation.”
BackgroundZhou, P., Xie, W., Luo, Y., Lu, S., Dai, Z., Wang, R., Zhang, X., Li, G., Sun, G., & Sun, X. (2018) · Molecules · doi:10.3390/molecules23112912 · Cited by 86
“Thus, therapeutic strategies that regulate apoptosis and autophagy may be effective for atherosclerosis [14].”
BackgroundSelf-citationAutophagy is critical for group 2 innate lymphoid cell metabolic homeostasis and effector function
Galle-Treger, L., Hurrell, B. P., Lewis, G. M., Howard, E. D., Shafiei-Jahani, P., Banie, H., Razani, B., Soroosh, P., & Akbari, O. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.10.035 · Cited by 89
“Following the characterization of the Atg5−/− mouse model, we used TfebTG mice with an overexpression of the transcription factor “EB” (Tfeb), a master regulator of autophagylysosomal biogenesis and critical to drive autophagy induction as previously described (31, 32).”
MethodSelf-citationPupyshev, A. B., Klyushnik, T. P., Akopyan, A. A., Singh, S. K., & Tikhonova, M. A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106373 · Cited by 87
TFEB is a master regulator of tumor-associated macrophages in breast cancer
Li, Y., Hodge, J., Liu, Q., Wang, J., Wang, Y., Evans, T. D., Altomare, D., Yao, Y., Murphy, E. A., Razani, B., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000543 · Cited by 88
“18 21 However, the functions of TFEB are not limited to autophagy and lysosome biogenesis.”
Self-citationHu, G., Yuan, Z., & Wang, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114333 · Cited by 78
Kumar, S. R., Nanduri, R., Bhagyaraj, E., Kalra, R., Ahuja, N., Chacko, A. P., Tiwari, D., Sethi, K., Saini, A., Chandra, V., et al. (2020) · Autophagy · doi:10.1080/15548627.2020.1822088 · Cited by 79
“Lipophagy, a specific type of autophagy, has critical roles in lipid metabolism and in the pathogenesis of AS [12,18,21,53].”
BackgroundTargeting macrophage TFEB-14-3-3 epsilon Interface by naringenin inhibits abdominal aortic aneurysm
Jia, Y., Zhang, L., Liu, Z., Mao, C., Ma, Z., Li, W., Yu, F., Wang, Y., Huang, Y., Zhang, W., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00363-1 · Cited by 80
Yang, L., Tao, Y., Luo, L., Zhang, Y., Wang, X., & Meng, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.114988 · Cited by 81
Chen, Z., Ouyang, C., Zhang, H., Gu, Y., Deng, Y., Du, C., Cui, C., Li, S., Wang, W., Kong, W., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2026097 · Cited by 76
“sclerosis by inhibiting endothelial inflammation [42], modulating VSMC proliferation and migration [43], and reducing foam-cell formation from VSMCs [44] and macrophages [45].”
BackgroundTFEB drives PGC-1α expression in adipocytes to protect against diet-induced metabolic dysfunction
Evans, T. D., Zhang, X., Jeong, S., He, A., Song, E., Bhattacharya, S., Holloway, K. B., Lodhi, I. J., & Razani, B. (2019) · Science Signaling · doi:10.1126/scisignal.aau2281 · Cited by 79
Self-citationVascular autophagy in health and disease
Hughes, W. E., Beyer, A., & Gutterman, D. D. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0802-6 · Cited by 76
Zhou, Y., Yan, M., Pan, R., Wang, Z., Xue, T., Li, C., Xia, T., Liu, X., & Chang, Q. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113317 · Cited by 79
Wang, Y., Ding, W., & Li, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.005 · Cited by 81
“Consistently, TFEB activation has also been shown to reduce atherosclerosis in experimental models in vivo (102,103).”
BackgroundTargeting lipophagy in macrophages improves repair in multiple sclerosis
Haidar, M., Loix, M., Vanherle, S., Dierckx, T., Vangansewinkel, T., Gervois, P., Wolfs, E., Lambrichts, I., Bogie, J. F. J., & Hendriks, J. J. A. (2022) · Autophagy · doi:10.1080/15548627.2022.2047343 · Cited by 75
“Notably, the use of trehalose on atherosclerotic macrophages has been shown to reduce their lipid accumulation [11].”
BackgroundMethodInfluentialYou, Y., Bao, W., Zhang, S., Li, H., Li, H., Dang, W., Zou, S., Cao, X., Wang, X., Liu, L., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315516 · Cited by 72
Yu, Y., Sun, Q., Li, T., Ren, X., Lin, L., Sun, M., Duan, J., & Sun, Z. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128368 · Cited by 71
NLRP3 inflammasome in cardiovascular diseases: an update
Mo, B., Ding, Y., & Ji, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1550226 · Cited by 81
Liu, R., Cui, J., Sun, Y., Xu, W., Wang, Z., Wu, M., Dong, H., Yang, C., Hong, S., Yin, S., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00797-2 · Cited by 73
“macrophage apoptosis and IL-1β levels, thereby reducing atherosclerosis [33].”
BackgroundEpsin Nanotherapy Regulates Cholesterol Transport to Fortify Atheroma Regression
Cui, K., Gao, X., Wang, B., Wu, H., Kulandaisamy, A., Dong, Y., Xiao, Y., Jiang, X., Malovichko, M. V., Li, K. S., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321723 · Cited by 74
Yuan, Y., Yuan, L., Yang, J., Liu, F., Liu, S., Li, L., Liao, G., Tang, X., Cheng, J., Liu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47842-z · Cited by 75
“…the inhibition of autophagy could skew M φ polarization to a proin fl ammatory M1 phenotype 7 , and increasing evidence suggests that M φ autophagy is the underlying mechanism element responsible for in fl ammation-related diseases, including sepsis 8 , atherosclerosis 9 , and liver diseases 10,11 .”
Yang, Y., Wang, J., Guo, S., Pourteymour, S., Xu, Q., Gong, J., Huang, Z., Shen, Z., Diabakte, K., Cao, Z., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101501 · Cited by 68
“Because lysosomes mediate the degradation of diverse cargos through processes, such as autophagosome processing, deficiency of plaque macrophages is a critical factor associated with dysfunctional autophagy [46].”
BackgroundThe Unique Phenotype of Lipid-Laden Macrophages
van Eijk, M., & Aerts, J. M. F. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084039 · Cited by 63
“Importantly, it has been demonstrated that macrophage-specific expression of TFEB, which induces lysosomal biogenesis, is antiatherogenic [79,80].”
BackgroundTherapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer
Byun, S., Lee, E., & Lee, K. W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091959 · Cited by 69
Yuan, Y., Li, L., Zhu, L., Liu, F., Tang, X., Liao, G., Liu, J., Cheng, J., Chen, Y., & Lu, Y. (2020) · Stem Cells · doi:10.1002/stem.3144 · Cited by 66
“Sergin et al have revealed that overexpression of TFEB in Mφ is able to reverse the autophagy dysfunction of plaques, blunt Mφ apoptosis and pro-inflammatory IL-1β level, leading to reduced atherosclerosis.(17) Interestingly, in our study we found that not only the expression of TFEB, but also its activity was dramati…”
BackgroundNosaka, N., Martinon, D., Moreira, D., Crother, T. R., Arditi, M., & Shimada, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00207 · Cited by 64
Wang, Z., Gao, Z., Zheng, Y., Kou, J., Song, D., Yu, X. L., Dong, B., Chen, T., Yang, Y., Gao, X., et al. (2023) · Journal of Pineal Research · doi:10.1111/jpi.12855 · Cited by 62
“Macrophage‐specific autophagy defects have been shown to promote the development of AS, which is an important cause of inflammation in plaque.(40) By activating Sirtuin3, Mel mediates macrophage mitophagy to remove reactive oxygen species and reduces the secretion of proinflammatory factors, thus reducing AS plaque pr…”
BackgroundSelf-citationTuning macrophages for atherosclerosis treatment
Fang, F., Xiao, C., Li, C., Liu, X., & Li, S. (2022) · Regenerative Biomaterials · doi:10.1093/rb/rbac103 · Cited by 75
Use of acidic nanoparticles to rescue macrophage lysosomal dysfunction in atherosclerosis
Zhang, X., Misra, S. K., Moitra, P., Zhang, X., Jeong, S., Stitham, J., Rodríguez-Vélez, A., Park, A. C., Yeh, Y., Gillanders, W. E., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2108252 · Cited by 66
“intensity, and fibrous cap of aortic root or BCA sections via immunofluorescence staining and confocal microscopy (Zeiss LSM-700) as previously described [72].”
MethodSelf-citationTrehalose promotes the survival of random-pattern skin flaps by TFEB mediated autophagy enhancement
Wu, H., Chen, H. A., Zheng, Z., Li, J., Ding, J. H., Huang, Z., Jia, C., Shen, Z., Bao, G., Wu, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1704-0 · Cited by 62
TFEB-mediated lysosomal exocytosis alleviates high-fat diet–induced lipotoxicity in the kidney
Nakamura, J., Yamamoto, T., Takabatake, Y., Namba‐Hamano, T., Minami, S., Takahashi, A., Matsuda, J., Sakai, S., Yonishi, H., Maeda, S., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162498 · Cited by 60
“Furthermore, trehalose, a natural disaccharide (α,α-1,1-glucoside) that was reported to enhance TFEB nuclear translocation (34), increased the TFEB nuclear translocation and reduced HFD-induced formation of cytosolic vacuoles in PTECs (Supplemental Figure 3, C and D).”
BackgroundSelf-citationThe Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases
Zhu, S., Yao, R.-Q., Li, Y., Zhao, P., Ren, C., Du, X., & Yao, Y.-M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.667750 · Cited by 61
“TFEB takes a part in the metabolism of lipid by regulating lipid transport and lipophagy (Zechner et al., 2012), while overexpression of TFEB perturbs expressions of numerous genes covering fatty acid-binding, transport and oxidation (Settembre et al., 2013).”
BackgroundMitochondria orchestrate macrophage effector functions in atherosclerosis
Dumont, A., Lee, M., Barouillet, T., Murphy, A. J., & Yvan‐Charvet, L. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100922 · Cited by 60
Sharma, V., Makhdoomi, M. A., Singh, L., Kumar, P., Khan, N., Singh, S., Verma, H. N., Luthra, K., Sarkar, S., & Kumar, D. (2020) · Autophagy · doi:10.1080/15548627.2020.1725374 · Cited by 57
“Trehalosemediated nuclear translocation of TFEB and autophagy activation in macrophages was also recently implicated as a potential therapy for atherosclerosis [52].”
BackgroundNovel insights: Dynamic foam cells derived from the macrophage in atherosclerosis
Li, J., Meng, Q., Fu, Y., Yu, X., Ji, T., Chao, Y., Chen, Q., Li, Y., & Bian, H. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30300 · Cited by 61
Autophagy and Mitophagy as Essential Components of Atherosclerosis
Poznyak, A. V., Nikiforov, N. G., Wu, W., Kirichenko, T. V., & Orekhov, A. N. (2021) · Cells · doi:10.3390/cells10020443 · Cited by 63
“The decline in the autophagy-lysosome system of macrophages in both human and mouse atherosclerotic plaques was identified [34].”
BackgroundMiceli, C., Santin, Y., Manzella, N., Coppini, R., Berti, A., Stefani, M., Parini, A., Mialet‐Perez, J., & Nediani, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8067592 · Cited by 56
“Consequently, restoration of defective autophagy now appears as an important therapeutic strategy in the context of cardiovascular diseases [14, 15].”
BackgroundLysosome (Dys)function in Atherosclerosis—A Big Weight on the Shoulders of a Small Organelle
Marques, A. R. A., Ramos, C., Machado-Oliveira, G., & Vieira, O. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.658995 · Cited by 55
Galindo, C. L., Khan, S. R., Zhang, X., Yeh, Y., Liu, Z., & Razani, B. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2288272 · Cited by 61
“Indeed, activating TFEB promotes autophagic flux (e.g. autophagosome formation, fusion with lysosomes, etc.), and its overexpression restores macrophage lysosomal autophagy and is broadly atheroprotective [128,155].”
BackgroundSelf-citationJavaheri, A., Bajpai, G., Picataggi, A., Mani, S., Foroughi, L., Evie, H., Kovács, A., Weinheimer, C. J., Hyrc, K., Xiao, Q., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.127312 · Cited by 53
“In addition, multiple risk factors for heart failure, including diabetes mellitus and coronary artery disease, are associated with autophagic impairment in macrophages (27, 31), suggesting that alterations in macrophage autophagy may be a persistent phenotype of ischemic cardiomyopathy in humans.”
BackgroundMethodInfluentialSelf-citationChen, Y., Li, Q., Li, Q., Xing, S., Liu, Y., Liu, Y., Chen, Y., Liu, W., Feng, F., & Sun, H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02038 · Cited by 58
Autophagy in cardiovascular health and disease
Abdellatif, M., Ljubojević-Holzer, S., Madeo, F., & Sedej, S. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.022 · Cited by 58
Kowara, M., & Cudnoch‐Jędrzejewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073513 · Cited by 63
Lipophagy: a new player in CNS disorders
Haidar, M., Loix, M., Bogie, J. F. J., & Hendriks, J. J. A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.010 · Cited by 56
Molecular mechanisms and clinical implications of multiple forms of mitophagy in the heart
Saito, T., Hamano, K., & Sadoshima, J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa340 · Cited by 51
“Trehalose promotes translocation of TFEB from the cytosol to nucleus, thereby inducing autophagy-related genes in macrophages and cardiomyocytes.(64,71) Trehalase expressed in the intestine in mice and humans can degrade Trehalose.”
BackgroundPark, H.-J., Son, H.-J., Sul, O., Suh, J., & Choi, H. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.019 · Cited by 49
Transcription factor EB regulates cardiovascular homeostasis
Lu, H., Sun, J., Hamblin, M. H., Chen, Y. E., & Fan, Y. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2020.103207 · Cited by 52
“Trehalose reduces atherosclerosis in ApoE KO mice [47] and improves cardiac remodelling after myocardial infarction [58].”
BackgroundLysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis
Bonacina, F., Zhang, X., Manel, N., Yvan‐Charvet, L., Razani, B., & Norata, G. D. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01072-4 · Cited by 56
“The natural sugar trehalose was shown to induce lysosomal biogenesis by inducing TFEB activation as a consequence of partial and transient lysosomal damage 141,144 .”
Self-citationStachowicz, A., Wiśniewska, A., Kuś, K., Kiepura, A., Gębska, A., Gajda, M., Białas, M. B., Totoń‐Żurańska, J., Stachyra, K., Suski, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071552 · Cited by 47
“Moreover, it has been shown that the stimulation of the macrophage autophagy-lysosomal system through pharmacological or genetic interventions could be atheroprotective [9,19,26].”
BackgroundUsing trehalose to prevent and treat metabolic function: effectiveness and mechanisms
Zhang, Y., & DeBosch, B. J. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000568 · Cited by 55
Ackermann, K., Bonaterra, G. A., Kinscherf, R., & Schwarz, A. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.12.009 · Cited by 51
Metadata
- Authors
- Sergin, I., Evans, T. D., Zhang, X., Bhattacharya, S., Stokes, C. J., Song, E., Ali, S., Dehestani, B., Holloway, K. B., Micevych, P. S., Javaheri, A., Crowley, J. R., Ballabio, A., Schilling, J. D., Epelman, S., Weihl, C. C., Diwan, A., Fan, D., Zayed, M. A., & Razani, B.
- Affiliations
- Washington University in St. Louis (US)
- Telethon Institute Of Genetics And Medicine (IT)
- University Health Network (CA)
- University of South Carolina (US)
- Corresponding author
- Razani, Babak
- ORCID
- Venue
- Nature Communications
- Published
- 2017-06-07
- Volume
- 8
- Issue
- 1
- Pages
- 15750-15750
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5467270
- OpenAlex
- W2622769153
- Cited by
- 351
- References
- 52
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 35 · 2023: 35 · 2022: 50 · 2021: 55 · 2020: 50 · 2019: 32 · 2018: 31 · 2017: 5
- FWCI
- 25.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs (I01BX001969)
- Foundation for Barnes-Jewish Hospital
- National Heart, Lung, and Blood Institute (K08HL132060, R01HL116626, F31HL132434, K08HL098559, R01HL107594, T32HL007081, R01HL125838)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK056341, P30DK020579)
- National Center for Complementary and Integrative Health (P01AT003961)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- atherosclerosis, macrophages, TFEB, aggrephagy, trehalose, macrophage apoptosis, IL-1β, atherosclerotic plaque, autophagy dysfunction, atherosclerosis treatment
- MeSH terms
- Sequestosome-1 Protein, Animals, Autophagy, Humans, Lysosomes, Macrophages, Mice, Inbred C57BL, Mice, Transgenic, Microtubule-Associated Proteins, Trehalose, Mice, Knockout, Atherosclerosis, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.